The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Predicting therapeutic nanomedicine efficacy using a companion magnetic resonance imaging nanoparticle
Open accessAbstract
Magnetic nanoparticles predict the efficacy of drug-loaded polymeric nanoparticles in vivo, helping select for tumors more responsive to nanomedicine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bertrand, N., Wu, J., Xu, X., Kamaly, N., & Farokhzad, O. C. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.11.009 · Cited by 2,824
Self-citationEvidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles
Davis, M. E., Zuckerman, J. E., Choi, C. H. J., Seligson, D., Tolcher, A., Alabi, C. A., Yen, Y., Heidel, J. D., & Ribas, A. (2010) · Nature · doi:10.1038/nature08956 · Cited by 2,505
Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size
Cabral, H., Matsumoto, Y., Mizuno, K., Chen, Q., Murakami, M., Kimura, M., Terada, Y., Kano, M. R., Miyazono, K., Uesaka, M., et al. (2011) · Nature Nanotechnology · doi:10.1038/nnano.2011.166 · Cited by 2,429
Maeda, H., Nakamura, H., & Fang, J. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.10.002 · Cited by 2,376
Targeted polymeric therapeutic nanoparticles: design, development and clinical translation
Kamaly, N., Xiao, Z., Valencia, P. M., Radovic-Moreno, A. F., & Farokhzad, O. C. (2012) · Chemical Society Reviews · doi:10.1039/c2cs15344k · Cited by 1,730
Self-citationTargeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo
Farokhzad, O. C., Cheng, J., Teply, B. A., Sherifi, I., Jon, S., Kantoff, P. W., Richie, J. P., & Langer, R. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601755103 · Cited by 1,663
Self-citationPrabhakar, U., Maeda, H., Jain, R. K., Sevick-Muraca, E. M., Zamboni, W., Farokhzad, O. C., Barry, S. T., Gabizon, A., Grodzinski, P., & Blakey, D. C. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4561 · Cited by 1,485
Self-citationHrkach, J., Von Hoff, D., Ali, M. M., Andrianova, E., Auer, J., Campbell, T., De Witt, D., Figa, M., Figueiredo, M., Horhota, A., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003651 · Cited by 1,147
Self-citationKirpotin, D. B., Drummond, D. C., Shao, Y., Shalaby, M. R., Hong, K., Nielsen, U. B., Marks, J. D., Benz, C. C., & Park, J. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4199 · Cited by 1,125
Chauhan, V. P., Stylianopoulos, T., Martin, J. D., Popović, Z., Chen, O., Kamoun, W. S., Bawendi, M. G., Fukumura, D., & Jain, R. K. (2012) · Nature Nanotechnology · doi:10.1038/nnano.2012.45 · Cited by 1,101
Zhang, Q.-W., Liu, L., Gong, C.-Y., Shi, H.-S., Zeng, Y.-H., Wang, X.-Z., Zhao, Y.-W., & Wei, Y.-Q. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050946 · Cited by 1,039
Tumor Vascular Permeability, Accumulation, and Penetration of Macromolecular Drug Carriers
Dreher, M. R., Liu, W., Michelich, C. R., Dewhirst, M. W., Yuan, F., & Chilkoti, A. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj070 · Cited by 920
van der Pol, E., Coumans, F. A. W., Grootemaat, A. E., Gardiner, C., Sargent, I. L., Harrison, P., Sturk, A., van Leeuwen, T. G., & Nieuwland, R. (2014) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12602 · Cited by 917
Conditional mouse lung cancer models using adenoviral or lentiviral delivery of Cre recombinase
DuPage, M., Dooley, A. L., & Jacks, T. (2009) · Nature Protocols · doi:10.1038/nprot.2009.95 · Cited by 894
Fluorogenic probes for live-cell imaging of the cytoskeleton
Lukinavičius, G., Reymond, L., D'Este, E., Masharina, A., Göttfert, F., Ta, H., Güther, A., Fournier, M., Rizzo, S., Waldmann, H., et al. (2014) · Nature Methods · doi:10.1038/nmeth.2972 · Cited by 820
Imaging macrophages with nanoparticles
Weissleder, R., Nahrendorf, M., & Pittet, M. J. (2014) · Nature Materials · doi:10.1038/nmat3780 · Cited by 809 · cited 1×
“infiltration in both cancer (11, 12) and inflammation (13).”
BackgroundKraft, J. C., Freeling, J. P., Wang, Z., & Ho, R. J. Y. (2014) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23773 · Cited by 606
Dhar, S., Kolishetti, N., Lippard, S. J., & Farokhzad, O. C. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1011379108 · Cited by 513
Self-citationCancer Nanomedicine: From Drug Delivery to Imaging
Chow, E. K.-H., & Ho, D. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005872 · Cited by 491
Emerging applications for ferumoxytol as a contrast agent in MRI
Bashir, M. R., Bhatti, L., Marin, D., & Nelson, R. C. (2015) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.24691 · Cited by 371
Nanoparticle clearance is governed by Th1/Th2 immunity and strain background
Jones, S. W., Roberts, R. A., Robbins, G. R., Perry, J. L., Kai, M. P., Chen, K., Bo, T., Napier, M. E., Ting, J. P. Y., DeSimone, J. M., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci66895 · Cited by 197
Single-cell and subcellular pharmacokinetic imaging allows insight into drug action in vivo
Thurber, G. M., Yang, K. S., Reiner, T., Kohler, R. H., Sorger, P., Mitchison, T., & Weissleder, R. (2013) · Nature Communications · doi:10.1038/ncomms2506 · Cited by 194
Self-citationKoukourakis, M. I., Koukouraki, S., Giatromanolaki, A., Archimandritis, S. C., Skarlatos, J., Beroukas, K., Bizakis, J. G., Retalis, G., Karkavitsas, N., & Helidonis, E. S. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.11.3512 · Cited by 191
Statistical power calculations1
Lenth, R. V. (2007) · Journal of Animal Science · doi:10.2527/jas.2006-449 · Cited by 165
Soundararajan, A., Bao, A., Phillips, W. T., Perez, R., & Goins, B. (2009) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2009.02.004 · Cited by 145
Bao, A., Goins, B., Klipper, R. W., Negrete, G. R., & Phillips, W. T. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.059535 · Cited by 128
On the Role of Specific Interactions in the Diffusion of Nanoparticles in Aqueous Polymer Solutions
Mun, E. A., Hannell, C., Rogers, S. E., Hole, P., Williams, A. C., & Khutoryanskiy, V. V. (2013) · Langmuir · doi:10.1021/la4029035 · Cited by 121
SIMON, G. H., von Vopelius‐Feldt, J., Fu, Y., Schlegel, J., Pinotek, G., Wendland, M. F., Chen, M., & Daldrup-Link, H. E. (2005) · Investigative Radiology · doi:10.1097/01.rli.0000191367.61306.83 · Cited by 108
Demidenko, Z. N., Kalurupalle, S., Hanko, C., Lim, C.-U., Broude, E. V., & Blagosklonny, M. V. (2008) · Oncogene · doi:10.1038/onc.2008.82 · Cited by 102
Utility of a New Bolus-injectable Nanoparticle for Clinical Cancer Staging
Harisinghani, M. G., Ross, R. W., Guimarães, A. R., & Weissleder, R. (2007) · Neoplasia · doi:10.1593/neo.07940 · Cited by 97
Self-citationTolmachev, V., Stone‐Elander, S., & Orlova, A. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70088-7 · Cited by 95
Monoalkoxy BODIPYs─A Fluorophore Class for Bioimaging
Courtis, A. M., Santos, S. A., Guan, Y., Hendricks, J. A., Ghosh, B., Szantai‐Kis, D. M., Reis, S. A., Shah, J. V., & Mazitschek, R. (2014) · Bioconjugate Chemistry · doi:10.1021/bc400575w · Cited by 82
Platinum Compounds for High‐Resolution In Vivo Cancer Imaging
Miller, M. A., Askevold, B., Yang, K. S., Köhler, R. H., & Weissleder, R. (2014) · ChemMedChem · doi:10.1002/cmdc.201300502 · Cited by 57
Self-citationTang, Y., Kim, M., Carrasco, D. R., Kung, A. L., Chin, L., & Weissleder, R. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0027 · Cited by 52
Self-citationRao, S., Larroque‐Lombard, A., Peyrard, L., Thauvin, C., Rachid, Z., Williams, C., & Jean‐Claude, B. J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0117215 · Cited by 25
Cited by
Cancer nanomedicine: progress, challenges and opportunities
Shi, J., Kantoff, P. W., Wooster, R., & Farokhzad, O. C. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2016.108 · Cited by 5,873
Self-citationKamaly, N., Yameen, B., Wu, J., & Farokhzad, O. C. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00346 · Cited by 3,070
Self-citationProgress and challenges towards targeted delivery of cancer therapeutics
Rosenblum, D., Joshi, N., Tao, W., Karp, J. M., & Peer, D. (2018) · Nature Communications · doi:10.1038/s41467-018-03705-y · Cited by 2,220
Tumor targeting via EPR: Strategies to enhance patient responses
Golombek, S. K., May, J.-N., Theek, B., Appold, L., Drude, N., Kiessling, F., & Lammers, T. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.07.007 · Cited by 1,262
“ferumoxytol, the highest docetaxel concentrations and the best tumor response were observed in the group of high ferumoxytol accumulating tumors [213].”
Backgroundvan der Meel, R., Sulheim, E., Shi, Y., Kiessling, F., Mulder, W. J. M., & Lammers, T. (2019) · Nature Nanotechnology · doi:10.1038/s41565-019-0567-y · Cited by 1,234
Metadata
- Authors
- Miller, M. A., Gadde, S., Pfirschke, C., Engblom, C., Sprachman, M. M., Kohler, R. H., Yang, K. S., Laughney, A. M., Wojtkiewicz, G., Kamaly, N., Bhonagiri, S., Pittet, M. J., Farokhzad, O. C., & Weissleder, R.
- Venue
- Science Translational Medicine
- Published
- 2015-11-18
- Volume
- 7
- Issue
- 314
- Pages
- 314ra183-314ra183
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W2173359203
- Cited by
- 347
- References
- 35
- FWCI
- 12.72
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.